Insider · CIK 0001714563

Brennan Aoife

Reports to the SEC for 5 companies · WELLESLEY HILLS, MA

sec.gov

Transactions

Companies

Filings

CIK

0001714563

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	CLYMClimb Bio, Inc.S Sale	Director, President and CEO	SSale	−30.9K sh	$13.17	−$407K	87,731
2026-06-27	CLYMClimb Bio, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+68.8K sh	—	—	118,633
2026-06-27	CLYMClimb Bio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−68.8K sh	—	—	137,500
2026-06-11	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2026-01-06	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+700K sh	—	—	700,000
2025-06-30	CLYMClimb Bio, Inc.S Sale	Director, President and CEO	SSale	−20.6K sh	$1.22	−$25.2K	48,132
2025-06-27	CLYMClimb Bio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−68.8K sh	—	—	206,250
2025-06-27	CLYMClimb Bio, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+68.8K sh	—	—	68,750
2025-06-11	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31K sh	—	—	31,000
2025-01-13	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.15M sh	—	—	1,150,000
2024-06-27	CLYMClimb Bio, Inc. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+275K sh	—	—	275,000
2024-06-27	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+550K sh	—	—	550,000
2024-06-13	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2024-06-05	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+70K sh	—	—	70,000
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+12.3K sh	—	—	12,332
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+12.4K sh	—	—	12,352
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+19K sh	—	—	18,999
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+28.9K sh	—	—	28,943
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+43K sh	—	—	42,999
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+8,666 sh	—	—	8,666
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+9,999 sh	—	—	9,999
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−5,591 sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−3,733 sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−3,600 sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−9,999 sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−12.3K sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−12.4K sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−19K sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−28.9K sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−43K sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−8,666 sh	—	—	0
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+5,591 sh	—	—	5,591
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+3,733 sh	—	—	3,733
2023-11-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+3,600 sh	—	—	3,600
2023-06-09	KYNBKYNTRA BIO, INC.S Sale	Director	SSale	−2,739 sh	$17.52	−$48K	27,947
2023-06-09	KYNBKYNTRA BIO, INC.S Sale	Director	SSale	−1,994 sh	$16.74	−$33.4K	30,686
2023-06-07	KYNBKYNTRA BIO, INC.A Award	Director	AAward	+8,289 sh	—	—	32,680
2023-06-07	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+12.7K sh	—	—	12,666
2023-04-03	SYBXSYNLOGIC, INC.S Sale	Director, President and CEO	SSale	−19K sh	$0.58	−$11K	256,301
2022-06-16	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+25.7K sh	—	—	25,684
2022-06-16	KYNBKYNTRA BIO, INC.A Award	Director	AAward	+15.8K sh	—	—	24,391
2022-04-04	SYBXSYNLOGIC, INC.S Sale	Director, President and CEO	SSale	−8,894 sh	$2.45	−$21.8K	275,343
2022-02-04	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+434K sh	—	—	434,160
2022-02-04	SYBXSYNLOGIC, INC.A Award	Director, President and CEO	AAward	+107K sh	—	—	284,237
2021-05-26	KYNBKYNTRA BIO, INC.A Award	Director	AAward	+4,700 sh	—	—	8,614
2021-05-26	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,800 sh	—	—	7,800
2021-03-10	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+285K sh	—	—	285,000
2021-03-10	SYBXSYNLOGIC, INC.A Award	Director, President and CEO	AAward	+71.3K sh	—	—	177,317
2020-08-05	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10.4K sh	—	—	10,400
2020-08-05	KYNBKYNTRA BIO, INC.A Award	Director	AAward	+3,914 sh	—	—	3,914

Recent filings

Accepted (ET)
Jun 304
Brennan Aoife0001193125-26-291131
SEC(opens sec.gov)
Jun 124
Brennan Aoife0001193125-26-269395
SEC(opens sec.gov)
Jan 84
Brennan Aoife0001193125-26-007670
SEC(opens sec.gov)
Jul 14
Brennan Aoife0000950170-25-092284
SEC(opens sec.gov)
Jun 124
Brennan Aoife0001415889-25-016971
SEC(opens sec.gov)
Jan 154
Brennan Aoife0000950170-25-005840
SEC(opens sec.gov)
Jun 274
Brennan Aoife0000950170-24-078688
SEC(opens sec.gov)
Jun 174
Brennan Aoife0001415889-24-017154
SEC(opens sec.gov)
Jun 64
Brennan Aoife0001415889-24-015854
SEC(opens sec.gov)
Nov 144
Brennan Aoife0000950170-23-063927
SEC(opens sec.gov)

Companies

Address

C/O CLIMB BIO, INC. 20 WILLIAM STREET, SUITE 145

WELLESLEY HILLS, MA, 02481